Platinum complexes act as shielding agents against virus infection

Area of Science:

• Virology
• Materials Science
• Drug Development

Background:

• Enterovirus 71 and human metapneumovirus cause significant public health concerns.
• Current antiviral therapies have limitations in efficacy and resistance.
• Platinum complexes show potential for therapeutic applications.

Purpose of the Study:

• To investigate the antiviral properties of the substitution-inert polynuclear platinum complex (PPC), TriplatinNC.
• To elucidate the mechanism by which TriplatinNC protects cells from viral infections.
• To explore the potential of TriplatinNC as a novel antiviral agent.

Main Methods:

• Cell culture models for enterovirus 71 and human metapneumovirus infection.
• Biochemical assays to detect viral replication and cell viability.
• Analysis of TriplatinNC interaction with cell-surface glycosaminoglycans.
• Mechanistic studies on viral entry pathways.

Main Results:

• TriplatinNC demonstrated significant protection against enterovirus 71 and human metapneumovirus.
• The antiviral effect is mediated by the formation of adducts between TriplatinNC and cell-surface glycosaminoglycans.
• TriplatinNC was found to inhibit viral entry into host cells.
• The complex acts by shielding cells from viral attack, a novel 'metalloshielding' mechanism.

Conclusions:

• TriplatinNC is a potent antiviral agent effective against enterovirus 71 and human metapneumovirus.
• The mechanism involves blocking viral entry via glycosaminoglycan adduct formation.
• This study opens new avenues for developing metalloshielding antiviral drugs based on platinum complexes.